Near-term upsides however are limited given the spurt in stock prices
Hospitals to gain most with up to 3.5% dip on cost of funds; may add half a million beds, says rating agency
Book review of Empire of Pain: The Secret History of the Sackler Dynasty
Pharma exports from India witnessed over 18 per cent growth to USD 24.44 billion during the last financial year against USD 20.58 billion in FY20
Top executives from telecom, electronics, food processing, pharmaceuticals, steel, and textiles will interact with the PM on Friday via video conferencing
The product is a therapeutic equivalent generic version of Prevacid SoluTab delayed release orally disintegrating tablets approved by the US Food and Drug Administration (USFDA)
Glenmark Pharmaceuticals Ltd has been granted final approval by the United States Food and Drug Administration (USFDA) for Amphetamine Sulfate tablets USP
Amazon, Reliance recently announced their foray into e-pharma sector
Medecins Sans Frontieres (Doctors Without Borders) demanded that companies provide details around price, supply and distribution of any vaccine proven safe and effective
Making medicines is expensive, and it can take a very long time to get from the discovery of a drug to actually treating patients
Sun Pharmaceutical Industries Managing Director Dilip Shanghvi said the company''s strategy of developing the specialty business as an additional growth engine has started delivering results
More US launches and uptick in the Indian market are key near-term triggers
Drug major Lupin on Tuesday said it has received approval from the US health regulator for its Albuterol Sulfate Inhalation Aerosol, used for treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms. The approved product is a generic version of ProAir HFA of Teva Branded Pharmaceutical Products R&D, Inc. In a regulatory filing, Lupin said it has received approval from the United States Food and Drug Administration (USFDA) for its Albuterol Sulfate Inhalation Aerosol, 90 mcg (base)/actuation. Vinita Gupta, CEO, Lupin said: "The approval is timely as Albuterol MDI is a key rescue inhalation product for asthma patients who are at an increased risk of COVID-19-related complications. We look forward to launching the product this quarter and expect a steady ramp-up through the fiscal year. Quoting IQVIA moving annual total June 2020 data, Lupin said the total Albuterol Sulfate Inhalation Aerosol market had US sales of approximately USD 2.9 billion, of which the ...
However, price correction could lead to growth moderation in the near term
Ennoventure has designed a novel app to identify spurious goods
India's domestic pharmaceuticals market is expected to grow by 12% to 14% in the next three years while the export market may grow by 8% to 14%
PARIS (Reuters) - French healthcare company Sanofi SA has agreed to buy U.S. company Principia Biopharma Inc for around $3.7 billion, the companies said on Monday, strengthening Sanofi's presence in research and development (R&D) areas.
AstraZeneca Mexico's head said that Phase III trials were expected to conclude by November or December
The experimental drugs shortcut the process of antibody formation by giving concentrated versions of specific ones that worked best against the coronavirus in tests
Ciprodexis used in adults and children 6 months of age or older to treat certain types of infections caused by certain germs called bacteria